CLASS I Drug recall · Reported 7 Mar 2018 · FDA Enforcement Report

Levofloxacin in 5% Dextrose Injection, 250 mg recalled

AuroMedics Pharma is recalling Levofloxacin in 5% Dextrose Injection, 250 mg/ (5 mg/mL) Single-Use flexible container, distributed nationwide in the US. The recall was initiated on 12 Jan 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot CLF160003, exp May 2018
NDC55150-243, 55150-244, 55150-245
UPC0355150244478
Quantity recalled6,072 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0574-2018
FDA event ID
78932
Recalling firm
AuroMedics Pharma, East Windsor, NJ
Manufacturer
Eugia US LLC
Classification
Class I
Status
Terminated
Recall initiated
12 Jan 2018
FDA classified
1 Mar 2018
Reported
7 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Mold
Drug class
Antibiotics

Timeline

12 Jan 2018Recall initiated by company
1 Mar 2018Classified by FDA+48 days
7 Mar 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter; contains visible particulate matter identified as mold.

Product as listed by the FDA

Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Levofloxacin in 5% Dextrose Injection, 250 mg/ (5 mg/mL) Single-Use flexible container recalled?

Yes. AuroMedics Pharma recalled Levofloxacin in 5% Dextrose Injection, 250 mg/ (5 mg/mL) Single-Use flexible container on 12 Jan 2018. The recall is Class I and its status is Terminated. Recall number D-0574-2018.

Why was it recalled?

Presence of Particulate Matter; contains visible particulate matter identified as mold.

Which lots are affected?

Lot CLF160003, exp May 2018

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AuroMedics Pharma

All 36

Other Levofloxacin In 5% Dextrose recalls

All 4